KIMS Q2 FY26 results: revenue up, PAT dips; subsidiary merger approved

Pat NegativeExceptional ItemResults View source PDF Explain this filing

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹720.90

prior close

₹727.45

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.2%+0.8% vs market

Hospital peers, median of 20sector-0.1%+0.6% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Smallcap 250 and 0.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

-0.0

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6-0.2+0.8-0.1+0.6

Next day

-2.9-0.2-2.6-1.2-1.7

-6.8-0.4-6.4-1.9-5.0

-4.4+0.3-4.8-1.7-2.7

-6.1-0.1-6.1-2.2-3.9

-7.8+0.1-7.9-2.4-5.4

-7.1-0.2-6.9-2.0-5.1

15d

-4.7-1.9-2.8-2.7-2.0

-7.1-5.5-1.5-5.1-2.0

-13.3-1.4-11.9-6.2-7.1

-10.0-4.6-5.3-11.8+1.8

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KIMS posted Q2 FY26 standalone revenue of Rs 4,300 million, up 18% YoY. Standalone Q2 PAT was about Rs 636 million (EPS Rs 1.59). Consolidated half year PAT attributable to owners fell to Rs 1,455 million from Rs 1,832 million. The board also approved merging wholly-owned units KIMS Hospitals and Chalasani Hospitals into KIMS. Statutory auditors gave an unmodified opinion.

Likely market impact

Topline grew but bottomline declined. Subsidiary merger simplifies group structure and may bring operational efficiencies.